Breaking News Instant updates and real-time market news.

KMB

Kimberly-Clark

$129.96

-1.27 (-0.97%)

, HLX

Helix Energy

$7.09

-0.19 (-2.61%)

20:25
04/23/17
04/23
20:25
04/23/17
20:25

Notable companies reporting before Monday's open

Notable companies reporting before Monday's open, with earnings consensus, include Kimberly-Clark (KMB), consensus $1.55... Helix Energy (HLX), consensus (13c)... Hasbro (HAS), consensus 38c... Halliburton (HAL), consensus 3c.

KMB

Kimberly-Clark

$129.96

-1.27 (-0.97%)

HLX

Helix Energy

$7.09

-0.19 (-2.61%)

HAS

Hasbro

$96.03

0.02 (0.02%)

HAL

Halliburton

$47.06

-0.63 (-1.32%)

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 01

    May

  • 01

    May

  • 17

    May

  • 18

    May

KMB Kimberly-Clark
$129.96

-1.27 (-0.97%)

04/18/17
JEFF
04/18/17
INITIATION
Target $134
JEFF
Hold
Kimberly-Clark initiated with a Hold at Jefferies
Jefferies analyst Kevin Grundy started Kimberly-Clark with a Hold rating and $134 price target. The competitive environment is as difficult as it's been in years and emerging markets are unlikely to recover near-term, the analyst contends.
04/10/17
DBAB
04/10/17
NO CHANGE
DBAB
Deutsche sees Personal Care stocks giving up recent gains
Deutsche Bank analyst Faiza Alwy expects stocks in the Cosmetics, Household and Personal Care space to give up their recent gains. The market seems to have decided that 3G or Unilever (UN, UL) is interested in acquiring U.S. HPC stocks with the group up 11% year-to-date, Alwy tells investors in a research note. The analyst sees M&A as unlikely in the near-term and points out that interest rates are rising. Alwy keeps Hold ratings on Colgate-Palmolive (CL), Clorox (CLX), Edgewell Personal Care (EPC) and Kimberly-Clark (KMB).
03/21/17
JPMS
03/21/17
INITIATION
Target $139
JPMS
Neutral
Kimberly-Clark initiated with a Neutral at JPMorgan
JPMorgan analyst Andrea Teixeira started Kimberly-Clark with a Neutral rating and $139 price target.
03/10/17
03/10/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Dollar General (DG) downgraded to Neutral from Buy at Buckingham with the firm's analyst saying the environment has become more difficult since the bullish analyst day last spring. The firm's analyst said shares do not appear to fully factor in sales and margin challenges and sees risk to Street expectations. 2. MEDNAX (MD) downgraded to Neutral from Overweight at JPMorgan with analyst Gary Taylor citing valuation following the recent rally in the shares. The analyst says he can't with confidence bump up his $69 price target given the multi-year slowdown of organic growth and its high Medicaid payor exposure. 3. Loxo Oncology (LOXO) downgraded to Neutral from Buy at Citi with analyst Yigal Nochomovitz saying the stock is now fairly valued. The reflect the equity financing in January which expanded the share count and rising R&D spend, the analyst cut his price target for the shares to $45 from $49. He believes, however, that Loxo management is executing the business plan well. 4. Kimberly-Clark (KMB) downgraded to Hold on competition, valuation at Societe Generale with analyst Iain Simpson saying price competition in the U.S. has picked up as P&G is becoming more aggressive with its mid-tier Luvs and competition in Brazil and China remains "tough." The analyst expects cost cutting to drive margins and views cash returns as "robust," but said valuation has caught up with fundamentals. 5. Ionis Pharmaceuticals (IONS) downgraded to Sell from Neutral at Goldman with analyst Salveen Richter saying Ionis has a "lackluster" track record of developing successful drugs and ongoing toxicity across multiple drugs. If volanesorsen is approved for FCS, Richter expects safety/compliance issues and the launch focus on specialists will result in limited returns, similar to drug Kynamro for high cholesterol. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HLX Helix Energy
$7.09

-0.19 (-2.61%)

01/09/17
JRCO
01/09/17
DOWNGRADE
JRCO
Hold
Helix Energy downgraded to Hold from Accumulate at Johnson Rice
Johnson Rice downgraded Helix Energy to Hold and lowered its price target to $10 from $12 saying it was surprised by the recent equity offering given the large cash balance. Further, the firm's analyst expects declining floating rig count utilization to continue to put pressure on Helix's well intervention business and limited deepwater completion activity to impact the robotics business during 2017.
02/21/17
SPHN
02/21/17
UPGRADE
SPHN
Overweight
Helix Energy upgraded to Overweight from Equal Weight at Stephens
02/22/17
JRCO
02/22/17
UPGRADE
Target $10
JRCO
Accumulate
Helix Energy upgraded to Accumulate from Hold at Johnson Rice
Johnson Rice upgraded Helix Energy to Accumulate with a $10 price target citing increased confidence in estimates given visibility on Well Intervention work in the North Sea and successful joint marketing efforts with OneSubsea.
04/03/17
TUDR
04/03/17
UPGRADE
TUDR
Buy
Helix Energy upgraded to Buy from Hold at Tudor Pickering
HAS Hasbro
$96.03

0.02 (0.02%)

02/13/17
02/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Air Products (APD) reinstated with an Overweight at Barclays. 2. Hasbro (HAS) was initiated with a Buy at Goldman, while Mattel (MAT) was initiated with a Neutral. 3. Jagged Peak Energy (JAG) initiated with a Positive at Susquehanna. 4. Kimbell Royalty Partners (KRP) initiated with a Buy at Wunderlich. 5. HollyFrontier (HFC) reinstated with a Sell at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/14/17
UBSW
03/14/17
NO CHANGE
UBSW
Buy
UBS discusses scenarios for hypothetical Mattel/Hasbro merger
UBS analyst Arpine Kocharyan noted market speculation about a potential merger of Hasbro (HAS) and Mattel (MAT). While admitting she has no view on the possibility of a deal happening, she does say there is large equity valuation gap between the two, with Mattel pricing in a potential dividend cut, and expressed her view that industry consolidation could pick up in 2017. Koocharyan maintains her Buy rating on Mattel and Neutral rating on Hasbro shares.
04/04/17
RILY
04/04/17
INITIATION
Target $111
RILY
Neutral
Hasbro initiated with a Neutral at B. Riley
B. Riley analyst Linda Bolton Weiser started Hasbro with a Neutral rating and $111 price target.
04/04/17
04/04/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Snap (SNAP) initiated with a Neutral due to valuation at BTIG. 2. HP Enterprise (HPE) initiated with a Hold at Berenberg. 3. Hasbro (HAS) initiated with a Neutral at B. Riley. 4. Lionsgate (LGF.A, LGF.B) initiated with a Buy at Canaccord. 5. Vistra Energy (VSTE) initiated with a Peer Perform at Wolfe Research. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
HAL Halliburton
$47.06

-0.63 (-1.32%)

04/19/17
04/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. ING Group (ING) initiated with a Buy at Jefferies. 2. T-Mobile (TMUS) was initiated with a Buy at SunTrust while Sprint (S), Verizon (VZ), and AT&T (T) were initiated with a Hold. 3. DXC Technology (DXC) initiated with an Overweight at JPMorgan. 4. LendingClub (LC) coverage resumed with a Hold at Stifel. 5. Halliburton (HAL) and Schlumberger (SLB) were initiated with a Buy at HSBC while Baker Hughes (BHI) was initiated with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/19/17
HSBC
04/19/17
INITIATION
Target $65
HSBC
Buy
Halliburton initiated with a Buy at HSBC
HSBC analyst David Phillips initiated Halliburton with a Buy and a $65 price target saying it stands to gain more than most from the underlying recovery in North America and expects pricing power to return as the market tightens and excess supply is absorbed.
03/07/17
GABE
03/07/17
NO CHANGE
GABE
Buy
Weatherford CEO choice ups chance of eventual Halliburton takeover, says Gabelli
Gabelli analyst Simon Wong said he was "pleasantly surprised" that Weatherford (WFT) appointed former Halliburton (HAL) CFO Mark McCollum as its new President and CEO and he views the selection "very favorably." The analyst, who said he has always believed that Halliburton is the most logical acquirer of Weatherford's portfolio of products, thinks the appointment of McCollum increases the likelihood that Halliburton will buy Weatherford "down the road." Wong has a Buy rating on Weatherford shares.
03/07/17
COWN
03/07/17
NO CHANGE
Target $7
COWN
Outperform
Weatherford remains top pick after CEO announcement, says Cowen
Cowen analyst Marc Bianchi noted Weatherford (WFT) has disappointed investors multiple times but he believes the company will be given another chance with its appointment of Mark McCollum as the new CEO. Bianchi sees the appointment of Halliburton's (HAL) former CFO as a net positive and said Weatherford remains a top pick. Bianchi reiterated his Outperform rating and $7 price target on Weatherford shares, which are up more than 15% to $6.80 in pre-market trading.

TODAY'S FREE FLY STORIES

TSLA

Tesla

$384.73

8.27 (2.20%)

14:26
06/22/17
06/22
14:26
06/22/17
14:26
Periodicals
Tesla in talks with labels on creating streaming service, Recode says 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

ESV

Ensco

$5.13

0.055 (1.08%)

14:25
06/22/17
06/22
14:25
06/22/17
14:25
Options
Ensco call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVO

Novo Nordisk

$43.77

0.06 (0.14%)

14:22
06/22/17
06/22
14:22
06/22/17
14:22
Hot Stocks
Novo Nordisk says CHMP endorses EU label update of Saxenda »

Novo Nordisk announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$32.60

0.18 (0.56%)

14:21
06/22/17
06/22
14:21
06/22/17
14:21
Hot Stocks
Roche reports FDA approval of Rituxan Hycela »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 13

    Jul

$NSD

NASDAQ Market Internals

14:17
06/22/17
06/22
14:17
06/22/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
06/22/17
06/22
14:16
06/22/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAVG

Navigators

$52.80

-0.4 (-0.75%)

14:15
06/22/17
06/22
14:15
06/22/17
14:15
Initiation
Navigators initiated  »

Navigators initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

WDR

Waddell & Reed

$19.55

0.73 (3.88%)

, IVZ

Invesco

$35.07

0.27 (0.78%)

14:14
06/22/17
06/22
14:14
06/22/17
14:14
Recommendations
Waddell & Reed, Invesco, T. Rowe Price analyst commentary  »

Waddell & Reed…

WDR

Waddell & Reed

$19.55

0.73 (3.88%)

IVZ

Invesco

$35.07

0.27 (0.78%)

TROW

T. Rowe Price

$73.04

-0.3 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

RAD

Rite Aid

$3.15

-0.0443 (-1.39%)

, WBA

Walgreens Boots Alliance

$78.12

-0.18 (-0.23%)

14:13
06/22/17
06/22
14:13
06/22/17
14:13
Periodicals
Capitol Forum says Lipsky reccomends blocking Rite Aid deal, Bloomberg says »

The FTC is said to be set…

RAD

Rite Aid

$3.15

-0.0443 (-1.39%)

WBA

Walgreens Boots Alliance

$78.12

-0.18 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

MDRX

Allscripts

$12.19

0.11 (0.91%)

14:10
06/22/17
06/22
14:10
06/22/17
14:10
Options
Allscripts attracts bullish option flow as shares see strength »

Allscripts attracts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$6.43

-0.37 (-5.44%)

14:05
06/22/17
06/22
14:05
06/22/17
14:05
Options
Sears call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNK

Cinemark

$38.39

-1.43 (-3.59%)

, RGC

Regal Entertainment

$20.46

-0.3 (-1.45%)

14:02
06/22/17
06/22
14:02
06/22/17
14:02
Hot Stocks
Analyst says sell Cinemark on weaker theater outlook, VOD threat »

Credit Suisse downgraded…

CNK

Cinemark

$38.39

-1.43 (-3.59%)

RGC

Regal Entertainment

$20.46

-0.3 (-1.45%)

AMC

AMC Entertainment

$22.70

-0.35 (-1.52%)

IMAX

IMAX

$23.40

-0.8 (-3.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLM

Martin Marietta

$228.17

1.08 (0.48%)

14:01
06/22/17
06/22
14:01
06/22/17
14:01
Hot Stocks
Martin Marietta announces Lloyd to retire as CFO »

Martin Marietta Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

AAL

American Airlines

$48.43

0.4 (0.83%)

13:59
06/22/17
06/22
13:59
06/22/17
13:59
Periodicals
American Air CEO: Not particularly excited about Qatar overture, Bloomberg says »

According to a letter to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 26

    Jun

  • 07

    Jul

HMC

Honda

$27.57

0.004 (0.01%)

, NSANY

Nissan

$19.09

-0.02 (-0.10%)

13:55
06/22/17
06/22
13:55
06/22/17
13:55
Periodicals
Honda, Nissan, Toyota to support Takata through recovery, Nikkei reports »

Japanese auto giants…

HMC

Honda

$27.57

0.004 (0.01%)

NSANY

Nissan

$19.09

-0.02 (-0.10%)

TM

Toyota

$105.48

0.92 (0.88%)

TKTDY

Takata

$2.25

0.45 (25.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

SNCR

Synchronoss

$10.65

0.47 (4.62%)

, T

AT&T

$38.22

0.065 (0.17%)

13:53
06/22/17
06/22
13:53
06/22/17
13:53
Recommendations
Synchronoss, AT&T, Verizon analyst commentary  »

Synchronoss comments on…

SNCR

Synchronoss

$10.65

0.47 (4.62%)

T

AT&T

$38.22

0.065 (0.17%)

VZ

Verizon

$45.54

0.125 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 27

    Jul

DIS

Disney

$104.39

-0.41 (-0.39%)

13:49
06/22/17
06/22
13:49
06/22/17
13:49
Hot Stocks
Ron Howard takes over director duties on 'Han Solo' film »

Lucasfilm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

SPWR

SunPower

$7.68

0.17 (2.26%)

, FSLR

First Solar

$37.23

1.78 (5.02%)

13:47
06/22/17
06/22
13:47
06/22/17
13:47
Hot Stocks
Solar stocks surge after Trump floats idea of sun-powered border wall »

Solar stocks soared…

SPWR

SunPower

$7.68

0.17 (2.26%)

FSLR

First Solar

$37.23

1.78 (5.02%)

JKS

JinkoSolar

$20.55

1.15 (5.93%)

CSIQ

Canadian Solar

$13.99

0.94 (7.20%)

JASO

JA Solar

$6.41

0.14 (2.23%)

TSLA

Tesla

$376.40

4.16 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 29

    Jun

  • 02

    Oct

AZN

AstraZeneca

$35.50

0.62 (1.78%)

13:45
06/22/17
06/22
13:45
06/22/17
13:45
Options
AstraZeneca call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

PCRFY

Panasonic

$13.65

0.123 (0.91%)

13:37
06/22/17
06/22
13:37
06/22/17
13:37
Periodicals
Panasonic aims to double cumulative dishwasher sales by 2026, Nikkei says »

Panasonic said it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:35
06/22/17
06/22
13:35
06/22/17
13:35
General news
NY Fed accepted $195.14 B in daily reverse repos »

NY Fed accepted $195.14 B…

SNCR

Synchronoss

$10.65

0.47 (4.62%)

, VZ

Verizon

$45.52

0.11 (0.24%)

13:30
06/22/17
06/22
13:30
06/22/17
13:30
Earnings
Synchronoss sees 'negligible' 2017 revenue impact from AT&T 'Locker' shut down »

In a business update…

SNCR

Synchronoss

$10.65

0.47 (4.62%)

VZ

Verizon

$45.52

0.11 (0.24%)

T

AT&T

$38.22

0.07 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 27

    Jul

PPC

Pilgrim's Pride

$23.33

-0.07 (-0.30%)

13:30
06/22/17
06/22
13:30
06/22/17
13:30
Options
Meaty put activity in Pilgrims Pride »

Meaty put activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$243.51

0.56 (0.23%)

, SPX

S&P 500

13:25
06/22/17
06/22
13:25
06/22/17
13:25
Technical Analysis
Technical View: S&P 500 in small very short-term bullish price channel »

Heading into afternoon…

SPY

SPDR S&P 500 ETF Trust

$243.51

0.56 (0.23%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTIC

CTI BioPharma

13:24
06/22/17
06/22
13:24
06/22/17
13:24
Hot Stocks
Breaking Hot Stocks news story on CTI BioPharma »

Stonepine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.